The effect of carnitine, fatty acyl carnitine, and fatty acyl coenzyme A on mitochondrial contraction.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000418:Albumins / Q000494:pharmacology; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D002247:Carbon Isotopes; D002331:Carnitine / Q000494:pharmacology*; D003065:Coenzyme A / Q000494:pharmacology*; D003486:Cyanides / Q000494:pharmacology; D006027:Glycosides / Q000494:pharmacology; D008055:Lipids / Q000032:analysis; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects*; D009243:NAD / Q000494:pharmacology; D009829:Oleic Acids / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D010169:Palmitic Acids / Q000378:metabolism; D051381:Rats
D000418:Albumins; D002247:Carbon Isotopes; D003486:Cyanides; D006027:Glycosides; D008055:Lipids; D009829:Oleic Acids; D009840:Oligomycins; D010169:Palmitic Acids; D009243:NAD; D000968:Antimycin A; D000255:Adenosine Triphosphate; D008274:Magnesium; D002331:Carnitine; D003065:Coenzyme A